Welcome to our dedicated page for Firsthand Technology Value Fund news (Ticker: SVVC), a resource for investors and traders seeking the latest updates and insights on Firsthand Technology Value Fund stock.
Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) is a publicly traded venture capital fund that invests in technology and cleantech companies, operating as a non-diversified, closed-end investment company that has elected to be treated as a business development company. The Fund regularly issues press releases detailing its financial results, portfolio valuation changes, and other significant developments, which form the core of the news flow associated with SVVC.
News about Firsthand Technology Value Fund frequently covers quarterly and annual financial results, including net asset value (NAV) per share, net assets, and the composition of its portfolio across equity and debt investments, cash and cash equivalents, and other assets. These updates often describe how the Valuation Committee, working with an independent valuation firm and following the Fund’s valuation procedures and ASC 820, has adjusted the fair values of private portfolio companies based on performance, recent transactions, and sector market multiples.
Investors following SVVC news can also see disclosures about fee waiver arrangements with its investment adviser, Firsthand Capital Management, Inc., and how these agreements affect reported management fees and net investment income or loss. In addition, the Fund has announced strategic reviews, such as the engagement of Ladenburg Thalmann & Co. Inc. to evaluate strategic options aimed at increasing stockholder value.
This news page aggregates such announcements, giving readers a centralized view of the Fund’s periodic financial reporting, valuation changes, portfolio developments, and Board-level decisions. For those tracking a venture capital-style fund focused on technology and cleantech companies, SVVC news provides insight into how its portfolio and capital structure evolve over time.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $4.44 as of December 31, 2022. The fund's top five holdings include IntraOp Medical, Wrightspeed, Hera Systems, Revasum, and EQX Capital, which collectively account for 125.0% of the fund's preliminary net assets. Total investments sum up to $40.1 million, equating to approximately $5.82 per share. Cash and cash equivalents are about $0.10 per share. The complete financial details will be released in the annual report due in March 2023.
Firsthand Technology Value Fund (SVVC) reported its top five investments as of October 31, 2022. These holdings represent 95.4% of the Fund's estimated total investments, valued at approximately $46.8 million or $6.78 per share, including cash equivalents of $0.13 per share. The largest investment is in IntraOp Medical (44.3%), followed by Wrightspeed (25.8%), Hera Systems (15.6%), Revasum (7.1%), and EQX Capital (2.6%). A full financial report will be published in March 2023.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its third-quarter results for 2022, showing significant declines in net assets and investment performance. As of September 30, 2022, net assets decreased to approximately $38.4 million from $49.8 million in June. The fund recorded a total investment loss of around $8.3 million and a net investment loss of about $8.8 million. The fair value of the portfolio was approximately $46.6 million, translating to $6.76 per share, with cash and equivalents of $1.15 million.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary NAV of $5.58 as of September 30, 2022. The Fund's top five holdings included IntraOp Medical (54.0% of net assets), Wrightspeed (31.1%), Hera Systems (19.0%), Revasum (7.9%), and EQX Capital (3.1%). Total investments were reported at $46.6 million, or $6.76 per share. Notably, these top holdings made up 115.1% of the Fund’s preliminary net assets. The complete financial statements will be available in the upcoming quarterly report due in November 2022.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five investments as of August 31, 2022, totaling approximately $47 million, or $6.82 per share. These holdings, which include IntraOp Medical Corp., Wrightspeed, Hera Systems, Revasum, and EQX Capital, account for 93.7% of its total investments. IntraOp Medical represents 34.8%, while Wrightspeed follows closely at 34.1%. A detailed financial report will be released in November 2022, outlining performance metrics and changes since June 30, 2022.
As of July 31, 2022, Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings, representing 93.2% of estimated total investments of approximately $50.2 million, or $7.28 per share. Key holdings include:
- IntraOp Medical (32.6%)
- Wrightspeed (31.4%)
- Revasum (15.8%)
- Hera Systems (11.2%)
- EQX Capital (2.3%)
The Fund focuses on investments in technology and cleantech companies.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced that Hera Systems, a holding since 2015, will provide spacecraft for the U.S. Space Force's Tetra-5 program. This program aims to develop a prototype constellation for on-orbit refueling and autonomous collaboration. The contract, awarded to Orion Space Solutions, could total $44.5 million if fully exercised. Hera Systems will deliver advanced spacecraft and software for the mission.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its financial results for Q2 2022, revealing net assets of approximately $49.8 million or $7.22 per share, down from $87.4 million or $12.68 per share as of March 31, 2022. The Fund's total investment loss was about $3.8 million, leading to a net investment loss of approximately $4.5 million. Realized and unrealized losses on investments reached $33.1 million during the quarter. The Fund continues to manage its portfolio actively to enhance performance.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported a preliminary NAV of $7.22 as of June 30, 2022. The Fund's top five holdings—IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and Pivotal Systems—constitute 92.4% of its net assets. IntraOp Medical leads with 32.8% of net assets, while Wrightspeed follows with 30.7%. Total investments stood at $49.3 million or $7.16 per share. The complete financials will be part of the quarterly report in August 2022.
As of May 31, 2022, Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings, which comprise 92.4% of its estimated total investments of approximately $66.8 million. These include IntraOp Medical (32.2%), Wrightspeed (28.5%), Revasum (17.5%), Hera Systems (9.4%), and Pivotal Systems (4.9%). The Fund's estimated value per share stands at $9.70, with cash and equivalents at approximately $0.27 per share. A comprehensive financial report will be available in August 2022.